Literature DB >> 20370967

Age of onset of cannabis use is associated with age of onset of high-risk symptoms for psychosis.

Sara Dragt1, Dorien H Nieman, Hiske E Becker, Reinaud van de Fliert, Peter M Dingemans, Lieuwe de Haan, Thérèse A van Amelsvoort, Don H Linszen.   

Abstract

OBJECTIVE: Increasing interest in the prodromal stage of schizophrenia over the past decade led us to perform our study to monitor people at high risk for developing a psychosis. We hypothesized that cannabis use or a cannabis use disorder at a younger age relates to high-risk symptoms at a younger age.
METHOD: People referred to the Academic Medical Centre in Amsterdam, the Netherlands, with an ultra-high risk (UHR) for psychosis were interviewed with the Composite International Diagnostic Interview to assess their cannabis consumption. The Interview for the Retrospective Assessment of the Onset of Schizophrenia was used to collect data about age of onset of high-risk or prodromal symptoms. Nine high-risk symptoms were selected and clustered because of their known relation with cannabis use.
RESULTS: Among the 68 included participants, 35 had used cannabis (51.5%), of whom 15 had used recently. Twenty-two participants had been cannabis abusers or cannabis-dependent (32.4%) in the past. Younger age at onset of cannabis use was related to younger age of onset of the cluster of symptoms (rho = 0.48, P = 0.003) and also to 6 symptoms individually (rho = 0.47 to 0.90, P < 0.001 to 0.04). Younger age at onset of a cannabis use disorder was related to younger age of onset of the cluster of symptoms (rho = 0.67, P = 0.001) and also to 6 symptoms individually (rho = 0.50 to 0.93, P = 0.007 to 0.03).
CONCLUSION: Cannabis use or a cannabis use disorder at a younger age in a group with an UHR for transition to psychosis is related to onset of high-risk symptoms for psychosis at a younger age.

Entities:  

Mesh:

Year:  2010        PMID: 20370967     DOI: 10.1177/070674371005500308

Source DB:  PubMed          Journal:  Can J Psychiatry        ISSN: 0706-7437            Impact factor:   4.356


  21 in total

1.  Association between age at onset of psychosis and age at onset of cannabis use in non-affective psychosis.

Authors:  Juan A Galvez-Buccollini; Ashley C Proal; Veronica Tomaselli; Melissa Trachtenberg; Cristinel Coconcea; Jinsoo Chun; Theo Manschreck; Jerry Fleming; Lynn E Delisi
Journal:  Schizophr Res       Date:  2012-06-21       Impact factor: 4.939

2.  Cannabis and Canadian youth: evidence, not ideology.

Authors:  Sheryl Spithoff; Meldon Kahan
Journal:  Can Fam Physician       Date:  2014-09       Impact factor: 3.275

Review 3.  Is prevention a realistic goal for schizophrenia?

Authors:  Christian Kohler; Karin E Borgmann-Winter; Irene Hurford; Eli Neustadter; James Yi; Monica E Calkins
Journal:  Curr Psychiatry Rep       Date:  2014-04       Impact factor: 5.285

Review 4.  Cannabis use in individuals at clinical high-risk for psychosis: a comprehensive review.

Authors:  Megan S Farris; Mohammed K Shakeel; Jean Addington
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2019-12-03       Impact factor: 4.328

5.  Cannabis industry and medical cannabis clinics need regulation.

Authors:  Meldon Kahan; Anita Srivastava; Sarah Clarke
Journal:  Can Fam Physician       Date:  2019-12       Impact factor: 3.275

6. 

Authors:  Meldon Kahan; Anita Srivastava; Sarah Clarke
Journal:  Can Fam Physician       Date:  2019-12       Impact factor: 3.275

7.  Shades of vulnerability: latent structures of clinical caseness in prodromal and early phases of schizophrenia.

Authors:  Andrea Raballo; Anna Meneghelli; Angelo Cocchi; Davide Sisti; Marco B L Rocchi; Andrea Alpi; Maria T Cascio; Antonio Preti; Kurt Maurer; Heinz Häfner
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-07-09       Impact factor: 5.270

8.  Stratifying empiric risk of schizophrenia among first degree relatives using multiple predictors in two independent Indian samples.

Authors:  Triptish Bhatia; Elizabeth A Gettig; Irving I Gottesman; Jonathan Berliner; N N Mishra; Vishwajit L Nimgaonkar; Smita N Deshpande
Journal:  Asian J Psychiatr       Date:  2016-08-21

9.  Cannabis use and neurocognitive functioning in a non-clinical sample of users.

Authors:  April D Thames; Natalie Arbid; Philip Sayegh
Journal:  Addict Behav       Date:  2014-02-06       Impact factor: 3.913

10.  Environmental Risk and Protective Factors and Their Influence on the Emergence of Psychosis.

Authors:  Danielle A Schlosser; Rahel Pearson; Veronica B Perez; Rachel L Loewy
Journal:  Adolesc Psychiatry (Hilversum)       Date:  2012-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.